Immunotherapy with NK cells: recent developments in gene modification open up new avenues

被引：32

作者：

Reindl, Lisa Marie ^{[1
,2
]}

Albinger, Nawid ^{[1
,2
]}

Bexte, Tobias ^{[1
,2
]}

Mueller, Stephan ^{[1
,2
]}

Hartmann, Jessica ^{[3
]}

Ullrich, Evelyn ^{[1
,2
,4
]}

机构：

[1] Goethe Univ Frankfurt, Childrens Hosp, Frankfurt, Germany

[2] Goethe Univ Frankfurt, Expt Immunol, Frankfurt, Germany

[3] Paul Ehrlich Inst, Div Med Biotechnol, Langen, Germany

[4] Goethe Univ, Frankfurt Canc Inst, Frankfurt, Germany

来源：

ONCOIMMUNOLOGY | 2020年 / 9卷 / 01期

关键词：

CAR; NK cells; NK-92; cells; cell therapy; NATURAL-KILLER-CELL; CHIMERIC ANTIGEN RECEPTOR; T-CELLS; MESSENGER-RNA; NK-92; CELLS; HEMATOPOIETIC-CELLS; CORD BLOOD; IN-VITRO; ADOPTIVE TRANSFER; VIVO EXPANSION;

D O I：

10.1080/2162402X.2020.1777651

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Chimeric antigen receptor (CAR)-T cell therapies have achieved remarkable success. However, application-related toxicities, such as cytokine release syndrome or neurotoxicity, moved natural killer (NK) cells into focus as novel players in immunotherapy. CAR-NK cells provide an advantageous dual killing-capacity by CAR-dependent and -independent mechanisms and induce few side effects. While the majority of trials still use CAR-T cells, CAR-NK cell trials are on the rise with 19 ongoing studies worldwide. This review illuminates the current state of research and clinical application of CAR-NK cells, as well as future developmental potential.

引用

页数：12

共 120 条

[81] Survival of tissue-resident memory T cells requires exogenous lipid uptake and metabolism [J].

Pan, Youdong ;

Tian, Tian ;

Park, Chang Ook ;

Lofftus, Serena Y. ;

Mei, Shenglin ;

Liu, Xing ;

Luo, Chi ;

O'Malley, John T. ;

Gehad, Ahmed ;

Teague, Jessica E. ;

Divito, Sherrie J. ;

Fuhlbrigge, Robert ;

Puigserver, Pere ;

Krueger, James G. ;

Hotamisligil, Goekhan S. ;

Clark, Rachael A. ;

Kupper, Thomas S. .

NATURE, 2017, 543 (7644) :252-+

[82] Adoptive Transfer of Autologous Natural Killer Cells Leads to High Levels of Circulating Natural Killer Cells but Does Not Mediate Tumor Regression [J].

Parkhurst, Maria R. ;

Riley, John P. ;

Dudley, Mark E. ;

Rosenberg, Steven A. .

CLINICAL CANCER RESEARCH, 2011, 17 (19) :6287-6297

[83]

Phatarpekar PV, 2016, METHODS MOL BIOL, V1441, P267, DOI 10.1007/978-1-4939-3684-7_22

[84] The discontinuity theory of immunity [J].

Pradeu, Thomas ;

Vivier, Eric .

SCIENCE IMMUNOLOGY, 2016, 1 (01)

[85] Self-tolerance of natural killer cells [J].

Raulet, David H. ;

Vance, Russell E. .

NATURE REVIEWS IMMUNOLOGY, 2006, 6 (07) :520-531

[86] Engineering Natural Killer Cells for Cancer Immunotherapy [J].

Rezvani, Katayoun ;

Rouce, Rayne ;

Liu, Enli ;

Shpall, Elizabeth .

MOLECULAR THERAPY, 2017, 25 (08) :1769-1781

[87] CD27 is a thymic determinant of the balance between interferon-γ-and interleukin 17-producing γδ T cell subsets [J].

Ribot, Julie C. ;

deBarros, Ana ;

Pang, Dick John ;

Neves, Joana F. ;

Peperzak, Victor ;

Roberts, Scott J. ;

Girardi, Michael ;

Borst, Jannie ;

Hayday, Adrian C. ;

Pennington, Daniel J. ;

Silva-Santos, Bruno .

NATURE IMMUNOLOGY, 2009, 10 (04) :427-436

[88] The activation of natural killer cell effector functions by cetuximab-coated, epidermal growth factor receptor-positive tumor cells is enhanced by cytokines [J].

Roda, Julie M. ;

Joshi, Trupti ;

Butchar, Jonathan P. ;

McAlees, Jaclyn W. ;

Lehman, Amy ;

Tridandapani, Susheela ;

Carson, William E., III .

CLINICAL CANCER RESEARCH, 2007, 13 (21) :6419-6428

[89] First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation [J].

Romee, Rizwan ;

Cooley, Sarah ;

Berrien-Elliott, Melissa M. ;

Westervelt, Peter ;

Verneris, Michael R. ;

Wagner, John E. ;

Weisdorf, Daniel J. ;

Blazar, Bruce R. ;

Ustun, Celalettin ;

Defor, Todd E. ;

Vivek, Sithara ;

Peck, Lindsey ;

DiPersio, John F. ;

Cashen, Amanda F. ;

Kyllo, Rachel ;

Musiek, Amy ;

Schaffer, Andras ;

Anadkat, Milan J. ;

Rosman, Ilana ;

Miller, Daniel ;

Egan, Jack O. ;

Jeng, Emily K. ;

Rock, Amy ;

Wong, Hing C. ;

Fehniger, Todd A. ;

Miller, Jeffrey S. .

BLOOD, 2018, 131 (23) :2515-2527

[90] Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia [J].

Romee, Rizwan ;

Rosario, Maximillian ;

Berrien-Elliott, Melissa M. ;

Wagner, Julia A. ;

Jewell, Brea A. ;

Schappe, Timothy ;

Leong, Jeffrey W. ;

Abdel-Latif, Sara ;

Schneider, Stephanie E. ;

Willey, Sarah ;

Neal, Carly C. ;

Yu, Liyang ;

Oh, Stephen T. ;

Lee, Yi-Shan ;

Mulder, Arend ;

Claas, Frans ;

Cooper, Megan A. ;

Fehniger, Todd A. .

SCIENCE TRANSLATIONAL MEDICINE, 2016, 8 (357)

← 3 4 5 6 7 8 9 10 11 12 →